Sphinganine as a potentially relevant metabolite in pulmonary involvement of primary Sjögren’s syndrome
Open Access
- 12 December 2025
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (1) , 100961
Abstract
No abstract availableKeywords
Funding Information
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Shanxi Provincial Science and Technology Department (YDZJSX2022C031)
- National Natural Science Foundation of China (81973466)
This publication has 51 references indexed in Scilit:
- Lipid Metabolism: An Emerging Player in Sjögren’s SyndromeClinical Reviews in Allergy & Immunology, 2025
- Sphingosine-1-phosphate alleviates Sjögren’s syndrome-like symptoms via inducing autophagy and regulating status of Treg cells in NOD miceInternational Immunopharmacology, 2024
- Identification of potential salivary biomarkers for Sjögren’s syndrome with an untargeted metabolomic approachMetabolomics, 2023
- Characteristics and treatment responses of immune thrombocytopenia in patients with primary Sjögren syndromeInternational Immunopharmacology, 2023
- Involvement of aquaporin 5 in Sjögren’s syndromeAutoimmunity Reviews, 2023
- Development of an interpretable machine learning model associated with heavy metals’ exposure to identify coronary heart disease among US adults via SHAP: Findings of the US NHANES from 2003 to 2018Chemosphere, 2022
- Atf-6 Regulates Lifespan through ER-Mitochondrial Calcium HomeostasisCell Reports, 2020
- The UPR Activator ATF6 Responds to Proteotoxic and Lipotoxic Stress by Distinct MechanismsDevelopmental Cell, 2018
- Lactosylceramide‐Induced Phosphorylation Signaling to Group IVA Phospholipase A2 via Reactive Oxygen Species in Tumor Necrosis Factor‐α‐Treated CellsJournal of Cellular Biochemistry, 2017
- Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253Journal of Autoimmunity, 2006